LGALS3 and non-small cell lung carcinoma: In accordance with what we observed, the expression of Galectin-3 was identified as a marker for a low overall survival of different cancers such as colorectal, ovarian, and non-small cell lung cancer, serving as an anti-apoptotic, proangiogenic and invasive agent [44].